Pathogenetic and substitution correction of anemia in patients with malignant neoplasms
Anemia in patients with malignant neoplasms affects the quality of life of the patient and sometimes limits the timely implementation of antitumor treatment. In the pathogenesis of anemia of the malignant neoplasms the largest role play infiltration of the bone marrow by tumor cells, suppression of...
Saved in:
| Main Authors: | N. A. Romanenko, A. E. Alborov, S. S. Bessmeltsev, E. R. Shilova, S. V. Voloshin, A. V. Chechetkin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2020-10-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/435 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathogenesis and therapy of anemia in oncohemathology patients with recombinant erythropoietin agents (review)
by: N. A. Romanenko
Published: (2014-07-01) -
Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review)
by: N. A. Romanenko, et al.
Published: (2014-07-01) -
Baseline erythropoietin level predicts Luspatercept response in Chinese patients with myelodysplastic syndrome: a propensity score-matched analysis
by: Doudou Chang, et al.
Published: (2025-01-01) -
Anemia in cancer patients: current treatment options (review)
by: V. M. Chernov, et al.
Published: (2014-07-01) -
Comparison of cytokine secretion and study of their effect on erythropoiesis in patients with malignant neoplasms with anemia of chronic disease, iron deficiency anemia, and their combination
by: V. T. Sakhin, et al.
Published: (2023-05-01)